Primary FDA-Approved Indications
Secondβgeneration antihistamine with low sedation risk.
Allergic rhinitis (seasonal/perennial)
FDA ApprovedChildren and adolescentsLabel/guideline
Chronic urticaria
FDA ApprovedChildren and adolescentsLabel/guideline